Healthtech Investors in Europe

Atlantic Vantage Point (AVP), formerly AXA Venture Partners, is a global investment platform that became independent in 2024 following a management buyout from AXA. Founded in 2016, the firm focuses on supporting high-growth technology companies across various stages of development. With newfound strategic autonomy, AVP continues to foster innovation while preserving its legacy of institutional strength. AVP manages over €2.5 billion in assets through four core strategies: venture, early growth, growth, and fund of funds. The firm invests in enterprise software, fintech, digital health, cybersecurity, and consumer tech sectors. Its expansion team works closely with portfolio companies to provide strategic support, industry access, and scale-up capabilities. With offices in Paris, London, and New York, AVP leverages its transatlantic footprint to identify and nurture the next generation of tech leaders. Flagship initiatives like the €1.5 billion Growth Fund I, backed by AXA and the European Investment Fund, underscore AVP’s mission to accelerate technology innovation on a global scale.

Bosch Ventures, officially known as Robert Bosch Venture Capital GmbH (RBVC), is the corporate venture capital arm of the Bosch Group. Established in 2007, RBVC invests globally in innovative startups across all stages of development, focusing on technologies that are strategically significant to Bosch's future. RBVC's investment portfolio encompasses sectors such as automation, electrification, energy efficiency, enabling technologies, and healthcare systems. By leveraging Bosch's extensive global network and industry expertise, RBVC provides not only capital but also strategic support to its portfolio companies, fostering growth and innovation. With offices in Germany, the United States, Israel, and China, RBVC maintains a strong international presence. The firm typically invests between €500,000 and €10 million per company, with total assets under management exceeding €200 million.

Calm/Storm Ventures is a venture capital firm headquartered in Vienna, Austria, specializing in early-stage investments with a strong focus on healthtech and wellbeing startups. The firm positions itself as a pre-seed fund, aiming to be the first institutional investor in visionary founders who are building digital solutions to improve the quality of life and health outcomes globally. Founded by seasoned entrepreneurs and investors, Calm/Storm Ventures brings deep operational experience and a founder-centric approach to its portfolio. The firm actively supports startups not just with capital but with strategic guidance, network access, and a hands-on involvement throughout the early growth stages. Their investment thesis centers around digital health, femtech, mental health, and other impact-driven sectors. While headquartered in Austria, Calm/Storm Ventures has a broad geographic investment reach, targeting founders across Europe and selectively in the United States. Its commitment to socially impactful and scalable digital health solutions places it at the forefront of a growing VC segment prioritizing both profit and purpose.

Founded in 2015 by Mingpo Cai and Denis Barrier, Cathay Innovation is a global venture capital firm affiliated with Cathay Capital. The firm focuses on multi-stage investments in innovative startups across sectors such as artificial intelligence, fintech, digital health, consumer technology, and energy. With offices spanning North America, Europe, Asia, and Latin America, it leverages a global network to support founders in scaling their ventures internationally. In 2025, Cathay Innovation launched its largest fund to date—Fund III, a $1 billion investment vehicle focused on AI startups. The fund targets application-layer innovations in digital health, consumer apps, fintech, and energy/mobility. Strategic LPs include leading corporates such as Sanofi, TotalEnergies, and BNP Paribas Cardif, reinforcing the firm’s strong links between venture investment and corporate innovation. The firm invests from Series A to late-stage rounds with check sizes ranging from $5 million to $80 million. Already backing 14 companies through Fund III, including Nabla and Mogic AI, Cathay Innovation unites startups, investors, and corporates to deliver strategic growth. Its hybrid global-local model ensures unique market access and operational support to portfolio companies worldwide.

Clave Capital, founded circa 2002 and headquartered in Pamplona, Spain, is a venture capital and tech‑transfer investment firm with 20+ years of experience and over 90 investments across industrial SMEs, healthtech, energy, agri‑food and biotech sectors. The firm manages the **Clave Innohealth Fund** (≈€50 M first close, targeting €80 M) focused on early-stage health innovation—eHealth, medtech, biotech, nutrition—backed by CDTI/Innviierte and private investors. Typical checks range from €500K to €1M with follow-ons up to €3 M. Clave operates from its Pamplona headquarters and maintains a regional Valencia office. With a tight-knit team (~20 professionals), Clave combines financial investment with operational involvement, partnering closely with founders and university research centers to scale innovation-driven SMEs.

Gryphion is the single-family office of Rob Thielen, the founder and chairman of Waterland Private Equity, a major European investment firm. Based in Amsterdam, Netherlands, Gryphion serves as the private investment platform for the Thielen family, overseeing a portfolio that spans private equity, real estate, venture capital, and philanthropic interests. Gryphion was established to manage and preserve the wealth accumulated from Thielen’s career in private equity, particularly following the success of Waterland, which has grown into one of Europe’s most respected and high-performing private equity firms. With a strong background in mid-market buyouts and growth investments, Thielen brings a rigorous and strategic mindset to Gryphion’s capital allocation decisions. The office operates with a long-term investment horizon, seeking opportunities that combine stable returns with social and economic value creation. Gryphion’s portfolio includes direct investments in high-growth companies, co-investments alongside institutional funds, and diversified allocations across asset classes. It also maintains a presence in impact investing, with a focus on sustainability, education, and innovation. In addition to investment activities, Gryphion supports philanthropic endeavors aligned with the Thielen family's values. These include contributions to cultural institutions, academic research, and community development initiatives both in the Netherlands and internationally. Gryphion maintains a lean structure, relying on a small team of experienced professionals and strategic advisors. The family office emphasizes privacy and discretion, operating largely out of the public eye while maintaining strong governance and disciplined risk management practices. As a modern European family office, Gryphion reflects the blend of entrepreneurial success and responsible capital stewardship. It embodies the next phase of wealth management for one of Europe’s most successful private equity figures, with a focus on legacy, purpose, and long-term value.

Hayfin Capital Management LLP, founded in 2009, is a premier European alternative asset management platform specializing in providing critical debt, equity, and hybrid capital solutions tailored to meet diverse financing needs for corporates—including both sponsor-backed and non-sponsor entities—as well as real asset owners. The firm employs a value-investing approach across multiple strategies including Direct Lending, Special Opportunities, High-Yield Credit, Securitized Credit, and Private Equity Funds.Headquartered in London, Hayfin has expanded its global footprint with 13 offices spanning Europe, the United States, and a growing presence in Asia. Since inception, Hayfin has invested over €50 billion of capital across more than 500 portfolio companies, managing approximately €35 billion in assets under management. The firm’s investment philosophy combines deep market expertise, disciplined risk management, and a commitment to responsible investing, as evidenced by its signatory status to the Principles of Responsible Investment (PRI).Hayfin’s management team, including co-founders Tim Flynn (CEO) and Mark Tognolini (COO), emphasizes long-term partnership with clients and investors, fostering a culture of collaboration and innovation.

Founded in 2019 and headquartered in Munich, Germany, Hitachi Ventures is the global corporate venture capital (CVC) arm of Hitachi Group. Operating as a standalone, return‑driven fund with Hitachi as its sole limited partner, the firm focuses on building partnerships with visionary founders to drive breakthrough innovation across climate, health, digital and industrial sectors. With offices in Munich, Boston and Palo Alto, Hitachi Ventures invests globally in startups aligned with Hitachi’s mission of social innovation. Under the leadership of CEO & Managing Director Dr. Stefan Gabriel—who founded the CVC and brings over 20 years of venture and corporate innovation experience—the firm invests in early to mid‑stage startups (primarily pre‑seed to Series B/C). Hitachi Ventures provides both capital and strategic alignment with Hitachi’s business units, enabling collaboration and scale opportunities across industry, digital, environment and healthcare domains. The firm currently manages four funds, including Fund IV launched in February 2025 with a commitment of $400 million, bringing total assets under management to approximately $1 billion. Hitachi Ventures seeks startups primarily in Europe, Israel and North America, targeting areas like Industry 5.0, TechBio, AI/data infrastructure, circular economy solutions, decarbonization and frontier deep‑tech.

Founded in 2000 as Holtzbrinck Ventures and now independent, HV Capital is a venture capital firm headquartered in Munich (with an office in Berlin), supporting European startups at every stage—from early seed rounds to growth financing. Over its nine fund generations, the firm has built a strong track record backing iconic internet and technology disruptors across Europe. HV Capital deploys capital in rounds ranging from €0.5 million at seed level up to €60 million in growth stage investments, with follow‑on reserves up to €100 million per company. Its largest fund to date, Fund IX (closed in May 2023 at approximately €710 million), underscores the firm’s ability to support founders over the long haul. A continuation fund launched in 2022 (HV COCO Growth, €430 million) further demonstrates their commitment to multi‑phase backing. The firm targets sectors including fintech, B2B/SaaS, mobility, consumer marketplaces, healthtech, education and green‑tech. With €2.8 billion in assets under management as of mid‑2023, more than 225 companies backed, and a team of over 60 experienced professionals, HV Capital is one of Europe’s most active and established early‑stage and growth investors.

Insight Partners is a global growth‑stage investor that focuses exclusively on software and technology‑enabled businesses. Since its founding in 1995, the New York‑headquartered firm has deployed capital across more than 800 companies worldwide and guided over 55 of them to public offerings. With more than US$90 billion under management, Insight invests at every stage from minority growth rounds to majority buyouts, but always with an eye toward helping founders scale efficiently. The firm’s Onsite program provides portfolio companies with a dedicated team of operators, marketers, engineers and talent specialists who help drive product development, revenue growth, sales effectiveness and executive hiring. Insight’s portfolio spans vertical and horizontal software, cybersecurity, fintech, data analytics and digital infrastructure across North America, Europe, Israel and Asia. Unlike many investors, the firm is comfortable writing very large checks and often leads financing rounds. Insight prioritizes partnership, often remaining involved for years as companies expand into new markets or prepare for IPOs. Its culture blends analytical rigor with entrepreneurial empathy, rooted in the belief that enduring software companies are built through disciplined execution, customer obsession and continuous innovation.

Latitude Ventures is a London-based venture capital firm established in 2019 as the growth-stage sister fund to LocalGlobe. It focuses on investing in breakout companies at Series B and beyond, providing capital and support to help them scale globally. Operating under the Phoenix Court Group umbrella, Latitude Ventures collaborates closely with LocalGlobe and other associated funds to offer a comprehensive investment platform. This structure enables continuous support for startups from seed stages through to public markets. Latitude Ventures targets B2B technology companies that address significant, industry-agnostic challenges. The firm emphasizes solutions that deliver immediate ROI and have the potential to impact various sectors, including operations, manufacturing, supply chain, and workforce management.

Lightspeed Venture Partners is a global venture capital firm founded in 2000, specializing in multi-stage investments across enterprise, consumer, fintech, and healthcare sectors. With a mission to accelerate disruptive innovations, Lightspeed has backed over 500 companies worldwide, including notable names like Snap, Affirm, and Nutanix. The firm's collaborative approach and deep industry expertise have positioned it as a trusted partner for entrepreneurs aiming to build impactful businesses. Operating from 14 offices across the United States, Europe, Asia, and Israel, Lightspeed maintains a strong global presence. This extensive network enables the firm to identify and support promising startups in diverse markets. By providing not only capital but also strategic guidance, Lightspeed helps its portfolio companies navigate the challenges of scaling and innovation. As of 2025, Lightspeed manages approximately $28.2 billion in assets under management, reflecting its significant role in the venture capital landscape. The firm's commitment to fostering innovation and long-term partnerships continues to drive its success in supporting the next generation of industry leaders.

Munich Re Ventures (MRV) is the corporate venture unit of global reinsurer Munich Re. Since 2014 it has deployed more than $1 billion across early- and growth-stage companies tackling the future of risk—spanning insurtech, climate resilience, industrial IoT, cybersecurity, digital health and new mobility. Headquartered in San Francisco with satellite offices in NYC and Munich, MRV combines financial capital with Munich Re’s underwriting data, client network and 140-year industry know-how. Portfolio highlights include Hippo, At-Bay, Farmer’s Business Network, Snapsheet and Relay. The 30-strong team of investors and operators accelerates product validation, co-development and global scaling for its portfolio, delivering strategic value to both founders and the Munich Re Group.

Omega Funds is a global investment firm focused on identifying and supporting transformational companies in the life sciences sector. With a mission to improve human health, Omega Funds primarily invests in biopharmaceuticals, medical technologies, diagnostics, and digital health. The firm backs science-driven innovation and partners with entrepreneurs developing breakthrough products across the U.S. and Europe.Founded in 2004, Omega Funds manages approximately $2 billion in assets under management. Its investment strategy spans early to late-stage private companies, as well as select public market opportunities. Omega’s portfolio includes a wide range of pioneering biotech firms tackling high-impact areas such as oncology, rare diseases, neurodegeneration, and gene therapies.Headquartered in Boston, Massachusetts, with an additional presence in London, Omega Funds has built a reputation for deep sector knowledge, long-term support, and close collaboration with scientific founders. The firm often takes a hands-on approach, contributing to company strategy, governance, and clinical development to help build lasting and valuable businesses.As a specialist life sciences investor, Omega Funds continues to pursue opportunities that align with its vision of delivering meaningful therapeutic innovation. Its global perspective and scientific focus make it a key player in the advancement of next-generation healthcare solutions.

Optum Ventures, established in 2017 in partnership with UnitedHealth Group’s Optum business, is a dedicated corporate venture capital partner focused on transforming healthcare through innovation. With headquarters in Boston and a London presence, the firm launched with an initial $250 million fund and now manages over $2 billion across six funds, backing more than 70 to 110 startups worldwide. The firm invests stage-agnostically from seed to growth equity in companies building at the intersection of technology and healthcare. Its focus areas include digital health, data analytics, value-based care platforms, enterprise software, fintech and insurtech in healthcare, and other enabling infrastructure. Beyond capital, portfolio companies benefit from strategic access to Optum’s extensive network—spanning payers, providers, employers, and life sciences—and opportunities for pilot collaboration and scaling. Optum Ventures targets companies in the US and UK/Europe (and broader global health markets), seeking disruptive teams who can leverage data-driven technologies to improve access, affordability, quality, and personalization of care. Its portfolio includes firms across value-based care delivery, analytics platforms, virtual and behavioral health, AI diagnostics, and consumer engagement tools, all aligned with Optum’s vision of a more efficient, patient-focused healthcare system.

Pentland Ventures is the direct investment division of the Pentland Group, a family-owned business known for global brands like Speedo and Berghaus. The fund focuses on backing passionate entrepreneurs who are shaping the future by pioneering brands that improve life, particularly in health, wellness, and sustainability sectors. The firm invests primarily in early-stage companies, including pre-seed and seed rounds, with investment sizes ranging from $500,000 to $10 million. Their portfolio includes innovative startups in fitness, mental health platforms such as Unmind, enterprise software, health technology, and hiring and recruitment solutions. Pentland Ventures leverages its global reach and operational expertise to support startups in scaling and succeeding. Headquartered in London, Pentland Ventures operates as a corporate venture capital arm with a mission to invest in consumer brands and technologies that power the consumer economy. Their investment approach combines the conviction of a venture capital fund with the financial discipline of a private equity firm, focusing on sectors that promote health, sustainability, and innovation across Europe, North America, and other global markets.

Sapphire Ventures is a global venture capital firm specializing in growth-stage investments in enterprise software and technology companies. Founded in 1996 as SAP's corporate venture arm, it became independent in 2011 and rebranded as Sapphire Ventures in 2014. The firm focuses on partnering with visionary teams to scale companies of consequence, leveraging its extensive network and deep industry expertise. With over $11 billion in assets under management, Sapphire Ventures operates through three primary investment strategies: direct investments in growth-stage technology companies, fund investments via Sapphire Partners, and early-stage investments in sports, media, and entertainment through Sapphire Sport. The firm has invested in more than 170 companies globally, resulting in over 30 public listings and 45 acquisitions. Headquartered in Austin, Texas, Sapphire Ventures maintains additional offices in Menlo Park, San Francisco, New York, and London, enabling it to support companies across the U.S., Europe, and Israel. The firm's sector focus includes B2B SaaS, artificial intelligence, cybersecurity, fintech, health tech, and vertical SaaS, with typical investment sizes ranging from $10 million to $100 million.

Founded in 2018, SemperVirens Venture Capital is a Silicon Valley-based venture capital firm specializing in early-stage investments in B2B technology startups. The firm focuses on companies that are transforming the relationship between employers and employees in the realms of health tech, fintech, and workforce tech. SemperVirens employs a unique approach through its proprietary SemperSystem™, which connects entrepreneurs with a vast network of investors, HR leaders, and strategic partners. This system provides portfolio companies with tailored go-to-market strategies, operational support, and deep market insights to accelerate growth. With over $300 million in assets under management, SemperVirens has invested in more than 70 companies, including notable names like Brightline, Spring Health, and Fountain. The firm's commitment to fostering innovation and supporting visionary entrepreneurs continues to drive its investment approach and global expansion.